205 related articles for article (PubMed ID: 16564442)
1. Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge?
Carey Sampson M; Katz A; Constine LS
Semin Radiat Oncol; 2006 Apr; 16(2):67-76. PubMed ID: 16564442
[TBL] [Abstract][Full Text] [Related]
2. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases.
Kavanagh BD; McGarry RC; Timmerman RD
Semin Radiat Oncol; 2006 Apr; 16(2):77-84. PubMed ID: 16564443
[TBL] [Abstract][Full Text] [Related]
3. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
5. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.
Takeda A; Sanuki N; Kunieda E
World J Gastroenterol; 2014 Apr; 20(15):4220-9. PubMed ID: 24764660
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
Scorsetti M; Franceschini D; De Rose F; Comito T; Villa E; Iftode C; Navarria P; D'Agostino GR; Masci G; Torrisi R; Testori A; Tinterri C; Santoro A
Breast; 2016 Apr; 26():11-7. PubMed ID: 27017237
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiation therapy for oligometastases.
Lo SS; Fakiris AJ; Teh BS; Cardenes HR; Henderson MA; Forquer JA; Papiez L; McGarry RC; Wang JZ; Li K; Mayr NA; Timmerman RD
Expert Rev Anticancer Ther; 2009 May; 9(5):621-35. PubMed ID: 19445579
[TBL] [Abstract][Full Text] [Related]
8. Normal tissue toxicity after small field hypofractionated stereotactic body radiation.
Milano MT; Constine LS; Okunieff P
Radiat Oncol; 2008 Oct; 3():36. PubMed ID: 18976463
[TBL] [Abstract][Full Text] [Related]
9. [Trends in radiation therapy for the treatment of metastatic and oligometastatic disease in 2010].
Thariat J; Marcy PY; Lagrange JL
Bull Cancer; 2010 Dec; 97(12):1467-76. PubMed ID: 21220224
[TBL] [Abstract][Full Text] [Related]
10. Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors.
Baisden JM; Romney DA; Reish AG; Cai J; Sheng K; Jones DR; Benedict SH; Read PW; Larner JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1229-37. PubMed ID: 17513066
[TBL] [Abstract][Full Text] [Related]
11. Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer.
Larici AR; del Ciello A; Maggi F; Santoro SI; Meduri B; Valentini V; Giordano A; Bonomo L
Radiographics; 2011; 31(3):771-89. PubMed ID: 21571656
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for oligometastases.
Tree AC; Khoo VS; Eeles RA; Ahmed M; Dearnaley DP; Hawkins MA; Huddart RA; Nutting CM; Ostler PJ; van As NJ
Lancet Oncol; 2013 Jan; 14(1):e28-37. PubMed ID: 23276369
[TBL] [Abstract][Full Text] [Related]
13. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
McCammon R; Schefter TE; Gaspar LE; Zaemisch R; Gravdahl D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):112-8. PubMed ID: 18786780
[TBL] [Abstract][Full Text] [Related]
14. Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasis.
Baisden JM; Reish AG; Sheng K; Larner JM; Kavanagh BD; Read PW
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):620-5. PubMed ID: 16904845
[TBL] [Abstract][Full Text] [Related]
15. [Extracranial stereotaxic body irradiation: preliminary results and the Orleans hospital experience].
Wachter T; Bouscayrol H; Champeaux E; Verrelle P; Giraud P
Bull Cancer; 2008 Jan; 95(1):153-60. PubMed ID: 18230582
[TBL] [Abstract][Full Text] [Related]
16. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy for oligometastases.
Lo SS; Teh BS; Mayr NA; Olencki TE; Wang JZ; Grecula JC; Lu JJ; Timmerman RD
Discov Med; 2010 Sep; 10(52):247-54. PubMed ID: 20875346
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy for colorectal liver metastases.
van der Pool AE; Méndez Romero A; Wunderink W; Heijmen BJ; Levendag PC; Verhoef C; Ijzermans JN
Br J Surg; 2010 Mar; 97(3):377-82. PubMed ID: 20095016
[TBL] [Abstract][Full Text] [Related]
20. Physics and imaging for targeting of oligometastases.
Yin FF; Das S; Kirkpatrick J; Oldham M; Wang Z; Zhou SM
Semin Radiat Oncol; 2006 Apr; 16(2):85-101. PubMed ID: 16564444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
